Twelve episodes of acute fatty liver of pregnancy (AFLP) were diagnosed in 11 patients during the past 18 years in a general hospital in Santiago, Chile, with a prevalence of 1 per 15900 deliveries. Acute fatty liver of pregnency started between the 31st and 38th weeks of pregnancy, with malaise, vomiting, jaundice, and lethargy as the main clinical manifestations. Polydipsia (in nine episodes) and skin pruritus (in seven episodes) were unusual clinical findings. In two patients, pruritus started two and four weeks before AFLP, suggesting that an intrahepatic cholestasis of pregnancy preceded AFLP in those patients. Considering the current prevalence of both diseases in Chile, their association should be considered fortuitous. In another patient, two consecutive pregnancies were affected by AFLP, raising to three the number of reported patients with recurrent AFLP. In 11 episodes, liver biopsies supported the diagnosis ofAFLP by showing smali and midsized vacuolar cytoplasmic transformation as the most prominent histopathological feature. Positive intracellular fat staining was found in the four samples analysed. Studies by electron microscopy showed megamitochondria with paracrystaline inclusions in four samples. All the mothers survived, but fetal mortality was 58*3%. Several extrahepatic complications delayed maternal recovery for up to four weeks after delivery. This study confirms an improvement in maternal prognosis in AFLP, discusses the possibility of an epidemiological association with intrahepatic cholestasis of pregnancy, and increases the number of patients reported with recurrent AFLP.
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(Gut 1994; 35: 101-106) Acute fatty liver of pregnancy (AFLP) is an uncommon disease with well defined clinical, laboratory, and histopathological features, although none of them are pathognomonic. The first reports mostly described patients with acute or fulminant liver failure during the third trimester of pregnancy that caused high maternal and fetal mortality.'1-Subsequent publications also included patients with a less severe is roughly equivalent to 0 7 patients per year but Figure 1 shows that these episodes were unevenly distributed with time and 10 of them (83%) were diagnosed during the past seven years. Reference values in third trimester of pregnancy: bilirubin direct <4 Vmol/l; total < 18 ,tmol/l; alanine aminotransfera*e (ALT) <50 IU/i; alkaline phosphatases <400; prothrombin time 9-12 s;
white blood cell (WBC) count 3 2-9 8 x 109/1.
Mean age ofthe patients (29-1 years) and range (16 to 39 years) were similar to the population of normal pregnant women attending our hospital. Table I shows that most patients (eight) were primigravidas, but one patient had AFLP in her fifth pregnancy. The disease started between the 31st and 38th gestational weeks and in nine episodes delivery occurred less than one week after the clinical onset of AFLP. Caesarean sections were performed in eight episodes; in five of them because of fetal distress and in the other three because of stillbirth without spontaneous onset of labour. All the mothers survived. Perinatal mortality reached 58 3%. Four stillbirths were diagnosed before admission, two during a stay in hospital, and another baby died soon after birth. Their were eight males and four females, with only single pregnancies in this series.
The first symptom was usually malaise. Vomiting soon became prominent in almost every episode. Jaundice and lethargy were the next symptoms, occurring within one to five days (Table II) plates. Specific staining for fat showed intracellular fat vacuoles in biopsy samples from patients 5, 6 (episode b), 10, and 11. In patient 11, large fat vacuoles were seen as well as microvesicular fat (Fig 4) . Small ,:;* 4e (Figs 3 and 6 ). Four months later she was free of symptoms, with a normal physical examination, although moderately obese. Liver function tests gave a serum total bilirubin of 20 [tmol/l, mildly increased alkaline phosphatases, and y glutamyl transpeptidase (1-5 and three times over normal limits, respectively), normal alanine and aspartate aminotransferases, total bile salts, cholesterol, and triglycerides. Serum total protein and albumin concentrations were normal, with a minimal unspecific rise in y globulins. Serum glucose, creatinine, and urine analyses were normal. Determinations of antimitochondrial, antinuclear, antismooth muscle, extractable nuclear, and anticardiolipin (IgG and IgM by enzyme linked immunosorbent assay) antibodies were negative. Her baby was thriving normally with breast feeding.
Discussion
Previous reports in Chile have detected a low prevalence of AFLP in different geographic areas.4 5 Ethnic and other characteristics ofthe population assisted in public hospitals tend to be similar in all geographic areas in Santiago. Therefore, the prevalence detected in the present study in the eastern area of Santiago may be considered as representative of the epidemiological situation of the population at large in this city.
The diagnosis of AFLP in our patients was based on the development of an acute liver disease during the final weeks ofpregnancy, with the clinical, laboratory, and histopathological features previously reported as characteristic of this disease.39I'-19 Other causes of acute liver damage that may occur in pregnant women near term cannot be reasonably supported.
The lack of maternal mortality compared with other reports could be due, in part, to less severity of the disease and its complications. None of these patients had hepatic coma. Only two of them reached a stage III encephalopathy. In a previous experience in our hospital, five out of six patients with AFLP were admitted in hepatic coma and they died.20 Acute pancreatitis occurred in three of those patients whereas it was not detected in the recent series. Another relevant difference lies in the current availability of intensive care units, providing aggressive supportive care of liver failure and of the severe complications that often endanger maternal survival in AFLP.7-9 16 17 21 22 Fetal mortality remained high (58-3%). We endorse the statement that 'good clinical judgement' advises immediate delivery in patients with AFLP although with this policy baby survival has improved less than maternal survival.9 11-16 23-25 The rationale of a prompt delivery seems supported by the finding that no patient has yet recovered from AFLP before delivery." Patients 8 and 11 show ( Table I) that AFLP may appear or worsen in puerperium, as previously described.S 6 9 16 [25] [26] [27] [28] In the present series, pre-eclampsia was documented in only one patient (l1), despite its frequent association with AFLP.791315 Based on epidemiological, clinical, biochemical, and histopathological data, it has been proposed that AFLP and pre-eclampsia may have a close pathogenetic connection -for example, arterial hypertension, renal failure, and kidney lesions with fat accumulation in tubules are often found in patients with AFLP' 9 10 17 20 29-32; hyperuricaemia is a common finding in both diseases and it can be detected several days before their clinical onsets317 33-35; multiparous patients with AFLP often have a history of pre-eclampsia; AFLP and pre-eclampsia are more frequent in twin pregnancies '8 19 ; and the microvacuolar fatty transformation of hepatocytes that is considered a hallmark in the histopathological diagnosis of AFLP has also been found in liver biopsies of patients with pre-eclampsia. 36 By contrast, an association between AFLP and intrahepatic cholestasis of pregnancy, another disease typical oflate pregnancy, has not yet been so clearly documented. AFLP and cholestasis of pregnancy have clear cut differences in clinical characteristics, laboratory profile, histopathology, and in maternal prognosis. 189 Cholestasis of pregnancy has a genetic predisposition, but this has not been found for AFLP. Whereas the prevalence of cholestasis of pregnancy in Chile is estimated as 7% during the past 18 years (a figure considerably higher than in any other country), the prevalence ofAFLP in our hospital seems as low as in studies reported from other countries. 14 15 18 19 Vanjak et al recently reported a patient with pruritus suggestive of cholestasis of pregnancy that started during the 26th week of a first pregnancy. This was followed by the spontaneous delivery of a normal newborn in the 36th week and the development of AFLP immediately postpartum, with complete recovery after one month.37 They described this as 'an unusual but favourable association'. Two of our patients (7 and 8 in Table 2 43 Patient 6 in our series also had two consecutive pregnancies complicated by AFLP and in both episodes the diagnosis was supported by the histopathological findings. These three patients should stimulate the search for pathogenetic factors that could interfere with the normal course of more than one pregnancy in a woman. They now also make the obstetrical counselling of a patient more difficult after recovery from an episode of AFLP.
The low prevalence ofAFLP, the fact that it is usually a medical-obstetrical emergency, and the lack of a suitable experimental model, conspire against the possibility of doing prospective studies to identify its cause and to improve its treatment. Therefore, we still have to rely on case reports and retrospective studies to expand our knowledge about this disease.
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